FERTILITY TEST MARKET ANALYSIS

The global fertility test market was valued at US$ 537.2 Mn in 2022 and is forecast to reach a value of US$ 979.6 Mn by 2030 at a CAGR of 7.8% between 2023 and 2030. The global fertility test market is expected to witness robust growth due to the declining fertility rates among men and women and rising awareness among people about fertility testing devices. Furthermore, increasing demand/adoption of fertility test kits or testing devices and high prevalence of PCOS (polycystic ovary syndrome) among women is expected to boost the market growth. However, factors such as the high cost of fertility testing monitors and lack of predictive accuracy to confirm ovulation are expected to hamper growth of the global fertility test market.

Global Fertility Test Market: Regional Insights

Based on region, the global fertility test market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period due to the declining fertility rate among men and women, rising awareness among people about fertility testing devices, and introduction of technologically advanced products in the region. For instance, according to the United States Census Bureau, the fertility rate in the U.S. declined gradually from 1990 to 2019. In 1990, around 70.77 children were born every year for every 1,000 women aged 15-44. While, as of 2019, there were approximately 58.21 births per 1,000 women in that age group. This in turn is expected to propel the market growth.

Europe and Asia Pacific are also expected to witness significant growth in the global fertility test market owing to the declining fertility rate among men and women, increasing demand for fertility test devices, rising awareness among people, and introduction of novel products in these regions. For instance, according to the latest population projections issued by Eurostat, the EU's population will decrease by 6% between 1 January 2022 and 1 January 2100, equivalent to 27.3 million fewer people. Moreover, the birth rate declined across the EU in 2020, hitting a 60-year low of 4 million births, according to data published by Eurostat in April 2022.

Figure 1. Global Fertility Test Market Share (%), by Region, 2023

To learn more about this report, request a free sample copy

Global Fertility Test Market Drivers:

Declining fertility rates to augment market growth

One of the key factors expected to augment the growth of the global fertility test market over the forecast period is the declining fertility rates among men and women across the world. Worldwide, fertility has fallen from an average of 5 births per woman in 1950 to 2.3 births per woman in 2021, an indication of the increasing control that individuals are able to exercise over their reproductive lives. According to the United Nation's World Population Prospects 2022 (WPP) report, the global fertility rate, which stood at 2.3 overall in 2021, will hit the demographic tipping point of 2.1 by 2050, due to a globally synchronized decline in birth rates.

Increasing awareness among people to propel market growth

Another factor driving the growth of the global fertility test market is the rising awareness among people about fertility testing devices. For instance, due to the increasing awareness about fertility testing in both developed and developing countries, there has been an increase in the fertility rate among the population over the years. Several governments and organizations also organize camps and events to raise awareness among people about fertility testing devices. The world Infertility Awareness Month is celebrated every June to increase awareness regarding numerous infertility issues faced by couples/individuals across the world.

Global Fertility Test Market Opportunities:

Increasing demand or adoption of fertility testing devices is expected to provide significant growth opportunities for players in the global fertility test market. For instance, with the rising awareness among people about fertility testing, the demand and/or adoption of fertility testing devices is also increasing with a rapid pace. In August 2021, Inito, a home fertility test, launched in the U.S. The Inito device, paired with a smartphone application, is an at-home testing device that measures the actual hormone values for estrogen, luteinizing hormone, and progesterone, giving the users data to guide decisions through the conception process.

Increasing prevalence of PCOS (polycystic ovary syndrome) among women is expected to provide significant growth opportunities for players in the global fertility test market. For instance, PCOS can affect a person's fertility in different ways. Ovulation problems are usually the primary cause of infertility in women with PCOS. Many women have PCOD/PCOS but are not aware of it, which can result in infertility. According to the Centers for Disease Control and Prevention (CDC), PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of women of reproductive age in the United States.

Global Fertility Test Market Trends:

High demand for ovulation prediction kits is a recent trend

Ovulation prediction kits are used to detect the exact day of ovulation for a woman who is planning for a conception. Used correctly, these kits are over 97% effective in detecting luteinizing hormone (LH) surge, which is used as a marker for ovulation. These kits provide an accurate forecast of LH surge and subsequent ovulation, they are most effective when used together with other monitoring methods. Since ovulation prediction kits provide cost-effective fertility testing, the demand for the same is on the rise, and this trend is expected to continue over the forecast period.

Introduction of novel testing devices is another trend

With the increasing awareness among people about fertility testing devices, the demand - adoption of fertility testing devices is also increasing rapidly. Hence, players in the market are focusing on developing and launching advanced, easy to use testing devices in the market to meet the growing demand worldwide. According to CDC, one in eight couples has trouble conceiving or sustaining a pregnancy, owing to the age, health issues, or other factors. This indicates that there is a need for advanced, easy-to-use test testing devices in the market.

Global Fertility Test Market Restraints:

High cost of testing monitors to hinder market growth

One of the key factors expected to hamper the growth of the global fertility test market is the high cost of fertility testing monitors. For instance, fertility monitors are an effective way to measure temperature and hormone levels to predict ovulation and peak fertility. However, they cost of the fertility monitor is high. Fertility testing monitors can be found in the lowest price of US$ 13 and can range up to US$ 130. The average price of the fertility testing monitor with good quality ranges around US$ 70, and this price segment cannot be considered affordable for all consumers.

Lack of predictive accuracy to hamper market growth

Another factor which is hampering the growth of the fertility test market is the lack of predictive accuracy to confirm ovulation. For instance, the ovulation monitors are used to determine the time in the menstrual cycle when changes of getting pregnant are high. The test detects a rise in LH in the urine as the rise in this hormone signals the ovary to release egg. If used accurately, the monitor can deliver 99% accuracy. However, the monitor may not give reliable results for women with the PCOS as the LH level or estrogen hormone level is constantly high or multiple peaks can be seen. The results therefore can falsely reflect whether or not the female has ovulated.  

Figure 2. Global Fertility Test Market Share (%), by Product, 2023

To learn more about this report, request a free sample copy

Global Fertility Test Market Segmentation:

The global fertility test market report is segmented into Image Product, Mode of Purchase, and Region.

Based on Type, the market is segmented into Ovulation Prediction Kit, Fertility Monitors (Urine-based Ovulation Monitors, Saliva-based Ovulation Monitors, and Other Fertility Monitors), and Male Fertility Testing Products. Out of which, Ovulation Prediction Kit Segment is expected to dominate the fertility test market during the forecast period and this is attributed to the increasing demand or adoption of ovulation prediction kits worldwide.

Fertility Monitors Segment is also expected to witness significant growth in the near future and this is owing to the increasing demand or adoption of fertility monitors worldwide.

Based on Mode of Purchase, the market is segmented into OTC-based Products and Prescription-based Products. Out of which, OTC-based Products Segment is expected to dominate the market over the forecast period and this is attributed to the increasing demand for over the counter (OTC) fertility testing devices across the globe.

Based on Application, the market is segmented into Female Fertility Testing and Male Fertility Testing. Out of which, Female Fertility Testing Segment is expected to dominate the market during the forecast period and this is attributed to the increasing demand for female fertility testing products/devices around the world.

Male Fertility Testing Segment is also expected to witness significant growth in the near future and this is owing to increasing demand for male fertility testing products.

Based on End User, the market is segmented into Home Care Setting and Hospitals/Fertility Testing. Out of which, Home Care Setting Segment is expected to dominate the market over the forecast period and this is attributed to the increasing adoption of at-home testing devices.

Hospitals/Fertility Testing Segment is also expected to witness robust growth in the near future and this is owing to increasing awareness among people about fertility testing.

Global Fertility Test Market: Key Developments

In January 2022, Kindbody announced the launch of Kind at Home, its consumer products division to support people across their entire reproductive journey, beginning with simple-to-use at-home fertility hormone tests for both women and men.

In December 2021, Carrot Fertility announced the launch of new kit for people to perform at-home fertility hormone and related biomarker monitoring. A custom, one-of-a-kind test kit goes beyond traditional fertility hormone tests to offer a more complete picture of fertility health, enabling the earlier action and interventions from the comfort of home.

In March 2020, Proov gets FDA (the Food & Drug Administration) NOD for its at-home ovulation testing kit. Users can send away for the kit and get test strips, which can determine the presence of progesterone metabolite PdG in urine, which is linked to a woman's ovulation cycle. It is developed to help women find out if they are ovulating on a regular basis.  

Global Fertility Test Market: Key Companies Insights

The global fertility test market is highly competitive. This is attributed to the increasing demand for fertility testing devices in both developing and developed countries, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global fertility test market are Advacare Pharma, UEBE Medical, Abbott Laboratories, Quidel Corporation, HiLin Life Products Inc., Geratherm Medical AG, Fertility Focus Limited, Fairhaven Health LLC, Church & Dwight Co. Inc., and Prestige Brands Holdings Inc., among others.

*Definition: Fertility test can be used to detect ovulation and/or to diagnose infertility, an inability to reproduce by natural means. It is undertaken by both men and women to assess their fertility and various conditions associated with it.